| 000 | 01851 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515195149.0 | ||
| 264 | 0 | _c20100525 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1945-0257 | ||
| 024 | 7 |
_a10.1089/gtmb.2009.0126 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhalil, Salem H | |
| 245 | 0 | 0 |
_aMolecular monitoring of response to imatinib (Glivec) in chronic myeloid leukemia patients: experience at a tertiary care hospital in Saudi Arabia. _h[electronic resource] |
| 260 |
_bGenetic testing and molecular biomarkers _cFeb 2010 |
||
| 300 |
_a67-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDNA Primers _xgenetics |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
| 650 | 0 | 4 | _aGenes, abl |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSaudi Arabia |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAbu-Amero, Khaled K | |
| 700 | 1 | _aAl Mohareb, Fahad | |
| 700 | 1 | _aChaudhri, Naeem A | |
| 773 | 0 |
_tGenetic testing and molecular biomarkers _gvol. 14 _gno. 1 _gp. 67-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/gtmb.2009.0126 _zAvailable from publisher's website |
| 999 |
_c19327519 _d19327519 |
||